Many genetic alterations leading to cancer development have been identified and technical developments have been added, and molecular profiling has been established. The formation of a molecular profile is in its broadest sense and the identification of genetic abnormalities occurs within the cell. Moreover, occurrence of events is in proteins or protein networks. These developments are promising to increase the life span and rates of the cases with diagnostic and prognostic approaches (9) .
CRC develop due to accumulation of genetic and epigenetic changes. The development of CRC is assumed to primarily start with alteration of Wnt and (Transforming growth factor) TGF-Beta signal pathways and than activation of KRAS followed by the inactivation of APC and TP53 (10) (11) (12) . Large group of CRC (80-90%) occurs in this order. In the remaining 10-20%; mismatch repair system does not fulfill its function adequately which results in mutations and microsatellite instability (MSI) (10) (11) (12) . Another genetic classification model of CRC describes two subtypes: Chromosomal instability (CIN) type and (MSI) type (13) . First group is consisted of multiple chromosomal alterations together with P53 mutations and MSI, CpG island methylator phenotype (CIMP) on a genome wide level and BRAF mutations are observed in the second group (13, 14) . For CRC development, DNA methylation is accepted as third underlying mechanism after CIN and MSI. Changing of gene expression due to DNA methylation may contribute CRC initiation and development (15) (16) (17) . It is very well known that genome wide epigenetic alterations play important role not only in CRC but also in most of the cancers. Recently, genome wide transcriptomic studies have revealed five distinct molecular mechanisms in CRC which result in changes in genetic expression pattern (18) (19) (20) .
Latest discoveries also revealed that tumor location may also be important in CRC development (left vs right side CRC). Underlying molecular mechanism of right side colon cancer development seems more relevant with MSI, CIMP and frequently BRAF mutations, and TP53 mutations are rarely seen in CRC of right side. And for left sided CRC, copy number alterations and TP53 mutations are more frequent and left sided CRC is more relevant with MSI phenotype. CIMP is observed lower in left sided CRC (21, 22) .
Methylation profiles of CRC are widely studied to investigate and identify any molecular marker for early detection, any prognosisrelated marker, and markers for diseases classification, therapeutic target, and also for risk assesment (23) (24) (25) (26) . Early genome -wide DNA hypomethylation has been observed in CRC and LINE-1 (long interspersed nucleotide element 1) hypomethylation has been found connected with increased cancer related mortality and overall mortality in patients with CRC (27) (28) (29) .
To understand methylation profile and MSI in Turkish CRC samples, we have used methylation specific -PCR technique to examine six differentially methylated tumor-suppressor genes and we analyzed three microsatellite loci for MSI. Methylation of the APC, hMLH1, p16INK4A, p15, p73 and DAPK1 promoters were performed using methylation-specific PCR in 76 sporadic CRCs.We performed these analyses on sporadic CRC samples gathered from their paraffin embedded tissue blocks. We also performed MSI analysis of same samples and together with methylation profile we performed statistical analysis based on avaliable proporties of patient.
Methods

Patients and Specimens
The samples were surgical resection specimens of consecutive patients with CRC at Istanbul University, Faculyt of Medicine hospital in Turkey. This study was a retrospective study that is why we could not take informed consent from the patients. This study was conducted in accordance with the ethical principle of Helsinki Declaration. Paraffin block samples that were stored along side were used. Data such as age, tumor type and tumor stage were used. Inclusion criteria were having resection of CRC and being available of tissue block of the primary tumor. Exclussion criteria were having history or pathologic evidence of familial adenomatous polyposis or idiopathic inflammatory bowel disease, or family history of hereditary non-polyposis colorectal cancer syndrome. Thus, blocks of 76 patients were selected from pathology department of Istanbul Faculty of Medicine in 2001 through 2004. While we were chosing patients from avaliable data, we aimed to select equal number of patients in terms ofsex, age, histological characterization, tumor localization and stage.
Both tumor tissue and non-neoplastic control tissue were collected from patients. Each formalin-fixed paraffin embedded (FFPE) resection specimen was microdissected and DNA extracted as reported previously (30) .
Microdissection from FFPE Samples and DNA İsolation
10-15 tissue sections of a 10-micrometer-thick paraffin block taken from tumorogeneous and non-tumorogeneous distal part of the same patient were used.
First, paraffin was removed using xylene from the samples and 100% ethyl alcohol was added and the samples were precipitated. Then, tissue digestion buffer solution which includes proteinase K were added to lyse cells. Phenol/chloroform mixture (1/1 ratio) was added and centrifuged at 14.000 rpm for 3 minutes. The supernatant was taken and this process was repeated once more. The supernatant was taken up in new tubes. Fifty mL of 5M ammonium acetate was added to each of the tubes. After adding the chilled 100% ethyl alcohol, it was left at -20°C overnight. The next day, samples were centrifuged at 14.000 rpm for 30 minutes, then the supernatant was taken and left for drying. Samples were allowed to stand for 10-15 minutes at 55°C, then 50 mL of sterile H 2 O was added and they were allowed to stand at room temperature for at least 1 hour before measuring optical densities. Obtained DNA samples were maintained at -20°C until analyses were done.
Sodium Bisulfite Treatment of DNA
DNA treated with sodium bisulfite as previously described (30) . Briefly, 5mg of DNA were denaturated at 42°C for 30 min with 0.4M NaOH, incubated in 10mM hydroquinone, 3M (Sodium Bisulfite, Sigma, St Louis, USA) at 55°C for 16 hrs and purified with the (GeneClean III kit, Bio 101, Vista, USA). Prior to ethanol precipitation, DNA was desulfonated in 0.4M NaOH for 15 min at 37°C. DNA was resuspended in water and stored at -80°C.
Preparation of positive controls used in methylation (In Vitro methylation).
(Sss I enzyme, New England BioLabs, Ipswich, USA), which methylates cytosines in the presence of CpG dinucleotide through whole genome, was used to generate positive controls. This process also uses S-Adenyl Methionine (SAM, New England BioLabs, Ipswich, USA), as the methyl donor group.
Methylation-Specific PCR
Bisulfite-treated DNA was used in methylation-specific PCR (MSP) reactions for 6 genes. Table 1 shows the sequences of the primers used, specific for the methylated (M) and unmethylated (U) forms. And Table 2 presents the gene regions examined for methylation and the lengths of the regions amplified in the PCR. The amplification reactions contained 25 pmoles of each primer, 200 mM dNTP, 1U (Hotstart Taq polymerase and 1x Q buffer, Qiagen, Valencia, USA) with variable amounts of MgCl 2 and cycling conditions are shown in Figure 1 . All MS-PCR products were run in a 4% agarose gel.
Assay for Microsatellite Instability (MSI)
MSI was determined by fluorescently labeled PCR amplification kit for this purpose ("HNPCC Microsatellite Instability Test", Roche, Berlin, Germany). Normally, it consists of 5 markers from panel described by the American Cancer Association, International HNPCC colobaration group and German Cancer Research group. Although with this kit 5 markers were provided, we could manage to analyze only 3 loci: BAT25 (c-kit), D5S346 (APC) and D17S250 (hMSH2). Primer sequences are given in Table 3 .
Statiscal Analysis
To test methylation and MSI of one locus and its relationship with other loci in terms of methylation status and to make comparisons with outcome, we used Fisher's Exact test and if the sample size was smaller than 2, then we used Pearson test. Comparison of methylation status and nonparametric outcome were tested by the nonparametric Mann-Whitney U Test. All tests were done by (SPSS software 10.0, Chicago, IL, USA) for windows and p<0.05 was considered statistically significant with only 2-sided results of the tests.
Results
We analyzed the methylation status of 6 genes in 76 patients with sporadic CRC (27-86 years, median age 58.8 years). We analyzed MSI in neoplastic tissue and we compared it with normal peripheral mucosa in the same patient group. Since we were particularly interested in the correlations of methylation of tumor suppressor genes previously confirmed to be methylated in CRC, we prioritized our selection of genes to include APC Table 1 . Methylation and unmethylation of specific primers for each locus Methylation specific PCR (MSP) was used to determine methylation of p15, p16, p73, APC, DAPK1 and hMLH1. MSP reactions for each gene were first standardized using in vitro methylated DNA (IVM), which yielded a positive product with primers for the methylated form. Under our experimental MSP conditions, a consistent absence of an amplification product for the methylated form was observed in 15-20 different DNA samples obtained from peripheral blood mononuclear cells from healthy individuals. This indicated that methylation was tumor specific. Methylation was very common in CRC. In 15 samples (19.8%) there was no detectable methylation among those six loci. The frequency of methylation of each gene varied notably. The frequency of methylation is shown in Table 5 .
The frequency of methylation was 24% for hMLH1, 31.5% for APC, 19.6% for DAP-Kinase, 42.8% for p16, 30% for p15, and 17% for p73. To quantify the extent of methylation in our series of CRC, we calculated a methylation index (MI=ratio between the number of genes methylated and the number of genes analyzed) based on the 6 genes that demonstrated some degree of methylation. MI ranged brtween 0-0.83, with an average of 0.271 corresponding to 1.6 genes/sample and median was 0.225 and when we removed 15 samples which was not methylated in any loci, the average of MI was 0.337 (represent 2.13 genes/ sample) and median was 0.33.
For analyzing whether the coexistence of interrelationship between two different loci, we performed two-sided Fisher's exact test to understand whether one locus was methylated or un-methylated and whether methylation status of one locus was affected by another locus test results were shown in Table 6 .
We also performed MSI analysis for 3 loci by ABI Prisim 310 sequencher (Applied Biosystem, Foster City, CA, USA) in these group of samples. We compared tumor tissue samples with normal mucosal specimen for the same patients' samples. We analyzed MSI in C-kit, hMSH2 and APC micro satellite region. Among these 3 regions; for c-kit locus MSI was positive in 14 of 67 samples, for hMSH2 locus MSI was positive in 12 of 66 and for APC locus, 10 of 67 analyzed samples. In all samples; there was one locus MSI in 18 patients, 2 loci MSI in 10 patients and 3 loci MSI in 4 samples.
All the analyzed 3 loci of MSI and methylation of 6 genes were compared statistically with avaliable data (age, sex, tumor localization, tumor cell differentiation, histologic charecterization of tumor cell) of patients by SPSS 10.0 for Windows software. We observed p73 methylation was significantly related with left colon cancer (p=0.003, 2-sided), p16 methylation was seen in females more than males (p=0.029, 2-sided), p15 methylation was seen more related with the well differentiated tumor cells (p=0.028, 2-sided). Also, APC methylation was correlated with stage I tumor (p=0.05, 2-sided) and stage I tumor was related with rectum cancer (p=0.017). Age and methylation index were compared with the other parameters by nonparametric Mann-Withney U Test (SPSS for Windows software). According to test results, MSI in APC loci was positively corelated with methylation index (p=0.029), MSI in APC kit and c-kit loci wererelated with age (p=0.032 and p=0.011, respectively) and for both loci, instability was increasing with age. Among those 6 loci which we performed methylation analysis, only p73 methylation was related with age (p=0.017) and inverse relation was present between age and left colorectal cancer (p=0.015). MI was observed higher with stage I (p=0.006) and stage III (p=0.03) disease.
In the same patient group, MSI studies were performed using DNA samples isolated from paraffin blocks of tumor and peripheral mucosa. DNA was used from same patient group but additionaly we used paraffin blocks from distal healty region which wasalso used for MSI comparison.
The MSI kit was used for this aim and it was used to study microsatellite instability of three regions. These regions were microsatellites present in the C-kit, hMSH2 and APC regions. Microsatellite unstable tumors are tumors in which, a new allele is observed, which is not observed in healthy tissue samples, or a decrease in the number of alleles are analyzed when normal and tumor tissues are compared. 
Discussion
We investigated the methylation status of 6 gene regions using the methylation-specific PCR method from paraffin block samples of 76 patients with sporadic colorectal cancer. The most frequent methylation was observed in the p16 gene region (42.8%), followed by the methylation ratios in APC, p15, hMLH1, DAP kinase and p73 regions, respectively.
In similar studies, p16 methylation was found to be 10% (10/65, 39% of sporadic) (31), 28% (27/97) in Americans, 27% (13/48) in Jordanian society and 10% (7/68) in another study. We observed p16 gene methylation more frequent in females than in males in our study population (p=0.023). Although p16 gene methylation was more associated with mucinous carcinomas than other gene regions, there was no statistical significance (p=0.058). The methylation rate for p15 with the same chromosomal location was 69%, 39% (44/64) for sporadic and 30% (20/64) for our study group (31) . On the other hand studies from United States did not identify any methylation on this region (33) . In our study group, p15 gene methylation was associated with welldifferentiated tumor cells (p=0.009).
There are three members of the p53 gene family (p53, p63, p73) and transcriptional activation is specific to the sequences of gene products (34) (35) (36) . Functionally, overexpression of the p73 gene has been reported to activate the targets of p53, such as cell cycle inhibitor p21 (34) (35) . However, there are also significant differences between the genes that p53 and p73 activate. P53 and p73 proteins are involved in the development of the organism in response to DNA damage. It is known that p73 is involved in p53-like response to cell stress. Overexpression of P73 triggers apoptosis (34) (35) (36) (37) . These and similar observations suggest that p73 is a tumor suppressor gene that affects p73 expression in some tumor types. Different studies have shown that p73 broad methylation is present in different proportions and in different populations. Xu et al. (31) found p73 methylation in 63% (41/65) of the patients, whereas in our group this rate was 17%. Very strong correlation was found between left colon cancer and p73 gene methylation (p=0.003), and we observed that MSH2 was related with MSI, so it was related with p73 methylation (p=0.017). In addition, we found that the age was related with p73 methylation (p=0.017, Mann-Witney U test) .
Apopitosis-associated protein kinase (Dap-kinase1) is involved in different apoptosis systems as a calcium/calmodilin-dependent serine/thironine kinase. However, the mechanism of triggering apoptosis is not completely understood (38) . We determined in our study group that the methylation rate was 19.1% in the DAPK1 region. Xu et al. (31) did not identify methylation in 39 sporadic cases. Satoh et al. investigated DAPK1 methylation in a series of 9 colorectal cancers. Pehlivan et al. (32) worked on Turkish CRC samples and searched for 5 genes related with methylation and 2 of them were the same with the ones in our study (DAPK1 and p16). DAPK1 methylation was found in 53% of of CRC samples and 29% of methylation was in healty part of CRC. They concluded that DAPK1 was not directly related with cancer formation but it was considered as an important factor for sensitivity (32) . Mutation and methylation were found in MSI -H group. In our study group, there was no association between DAPK1 methylation, any features of the disease and methylation of other gene regions.
Loss of function in the APC gene results decrease in its product, a tumor suppressor protein, that it is known as the initiator. This causes development of multi-step cancer in the large intestine (39) . APC protein is directly related to β-catenin signaling proteins (40) . APC proteins are located in the microvessel network in vivo, whereas in vitro they cause polymerizations of tubules into microtubules (41) . Early-occurring mutant proteins lose ability to suppress the β-catenin/Tcf signaling pathway in regions close to the carboxy end of the APC gene (42) .
We observed APC methylation in 31.5% of our case group. There are reports in the literature that the rates of APC methylation are relatively low (8%) (31). Esteller et al. (43) showed the methylation of the APC region in 18% of 108 colorectal cancer cases examined. In another study, the methylation of the APC promoter was shown to be 28% of 137 colorectal cancer cases. Loss of heterozygosity and immunohistochemical staining of APC methylation are important in loss of gene expression and in the formation of second hit in the development of colorectal cancer (44) .
Homozygous deletions of p16 and p14 genes are frequently observed in lung and breast cancers, which are not encountered in colorectal cancers (45) . In contrast, methylation of p16 and p14 is more common in colorectal cancers (46) . APC promoter methylation is a similar condition, although methylation in gastric cancers is a more common condition Statistical analysis of the patient group showed that APC methylation was significantly associated only with the stage 1 disease group. This result was evaluated in the same direction as the rate limiting effect of the APC gene in the literature.
It is known that MSI, as a genetic finding, is an alternative pathway in the development of cancer after the detection of HNPCC and sporadic colorectal cancers (47) . In our samples, there was a significant correlation between microsatellite instability in the APC region and hMLH1 methylation (p=0.032) in the three regions where we performed the MSI study.
HMLH1 methylation was not statistically related to MSI in the c-kit region (p=0.054, 2-sided), and there was no significant correlation with MSI in the MSH2 region. We hypothesized that hMSH2 gene methylation may be significantly related to MSI in this region. It is reported that MLH1 and MSH2 mutations are not associated with low levels of MSI (48) . It has been suggested that the methylation state in DNA repair genes which are not involved in the MMR mechanism may be the cause of the MSI (49) . Interestingly, we found that only methylation in the p73 gene region was significantly associated with MSI in the MSH2 region (p=0.017, 2-sided), while other methylation regions were not significantly associated with MSI screening.
Furukawa and colleagues examined hMLH1 methylation in three regions and found to be associated with MSI-H, proximal colon cancer involvement with a type of methylation, termed type 1, which contained more than 80% of the CpG island. The methylation of the PTEN promoter region was highly related with increased MSIand was claimed to be a second hit in the HMLH1 methylation (50) . In our study group, the rate of HMLH1 methylation was 24% and it was found to be compatible with the literature (18%). Our samples were consisted of sporadic patients and there was no clinical relationship except HMLH1 methylation and MSI regions.
Co-methylation of some important tumor suppressor genes have been identified in some studies and it was defined as methylator phenotype of the relevant cancer. In this study, a similar relationship for CRC was not demonstrated for the 6 regions in which we studied. The most striking aspect of our results, could be summarized as, the association of p73 methylation with left colon involvement, correlation with MSI, and increasedmethylation with age. More frequent observation of p16 methylation in female gender and the fact that p15 methylation was associated with well differentiated cancers were the original results of our study for Turkish society.
Conclusion
We observed that APC methylation was more common in Turkish population than other populations. P16 was the most common methylated locus among the 6 gene regions and it seemed strongly related with female patients. P73 was releated with left colorectal cancer and additionally it was related with the MSI.
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